普洛药业隶属于横店集团。CDMO为普洛药业三大核心业务之一，致力于为全球制药公司提供从临床早期研究直至药品上市全生命周期所需的医药中间体及原料药定制研发生产服务，拥有”合成+发酵“的双轮驱动模式，建立流体化学、生物催化以及粉体晶体三大技术平台。目前公司在横店、上海、波士顿设立研发中心，在浙江、山东、安徽等拥有七大生产基地。
Apeloa Pharmaceutical Co., Ltd. belongs to Hengdian group. CDMO is one of Apeloa’s core businesses. CDMO BU is mainly providing contracting, developing and manufacturing service for top pharmaceutical companies in the world on RSM/GMP intermediate/API from early stage to commercial stage. Under the advantage of combining synthesis and fermentation together, flow chemistry，biocatalysis and crystallization platforms have been bulit. Apeloa has established R & D center in Hengdian, Shanghai and Boston, and owns 7 production sites located in Zhejiang, Shandong and Anhui, etc.